1. Home
  2. NKTR vs MYI Comparison

NKTR vs MYI Comparison

Compare NKTR & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$43.51

Market Cap

860.0M

Sector

Health Care

ML Signal

HOLD

Logo Blackrock MuniYield Quality Fund III Inc

MYI

Blackrock MuniYield Quality Fund III Inc

HOLD

Current Price

$10.93

Market Cap

713.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
MYI
Founded
1990
1992
Country
United States
United States
Employees
61
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
860.0M
713.9M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NKTR
MYI
Price
$43.51
$10.93
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$111.83
N/A
AVG Volume (30 Days)
978.3K
256.7K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
4.81%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.48
$9.32
52 Week High
$66.92
$11.70

Technical Indicators

Market Signals
Indicator
NKTR
MYI
Relative Strength Index (RSI) 39.03 53.05
Support Level $41.32 $10.68
Resistance Level $44.91 $10.86
Average True Range (ATR) 3.26 0.09
MACD -0.42 0.01
Stochastic Oscillator 14.61 76.67

Price Performance

Historical Comparison
NKTR
MYI

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is an investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes, as is consistent with its investment policies and prudent investment management. The fund invests a majority of its assets in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax). Under normal market conditions, the fund invests mainly in long-term municipal obligations that are investment-grade quality or are considered by the adviser to be of comparable quality at the time of investment. It can also invest directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: